Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

The changing opioid crisis: development, challenges and opportunities

ND Volkow, C Blanco - Molecular psychiatry, 2021 - nature.com
The current opioid epidemic is one of the most severe public health crisis in US history.
Responding to it has been difficult due to its rapidly changing nature and the severity of its …

Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study

MR Larochelle, D Bernson, T Land… - Annals of internal …, 2018 - acpjournals.org
Background: Opioid overdose survivors have an increased risk for death. Whether use of
medications for opioid use disorder (MOUD) after overdose is associated with mortality is not …

Management of opioid use disorder in the USA: present status and future directions

C Blanco, ND Volkow - The Lancet, 2019 - thelancet.com
Opioid use disorder is characterised by the persistent use of opioids despite the adverse
consequences of its use. The disorder is associated with a range of mental and general …

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): a multicentre, open-label …

JD Lee, EV Nunes, P Novo, K Bachrach, GL Bailey… - The Lancet, 2018 - thelancet.com
Background Extended-release naltrexone (XR-NTX), an opioid antagonist, and sublingual
buprenorphine-naloxone (BUP-NX), a partial opioid agonist, are pharmacologically and …

Neuroscience of addiction: relevance to prevention and treatment

ND Volkow, M Boyle - American Journal of Psychiatry, 2018 - Am Psychiatric Assoc
Addiction, the most severe form of substance use disorder, is a chronic brain disorder
molded by strong biosocial factors that has devastating consequences to individuals and to …

The opioid epidemic: crisis and solutions

P Skolnick - Annual review of pharmacology and toxicology, 2018 - annualreviews.org
The widespread abuse of prescription opioids and a dramatic increase in the availability of
illicit opioids have created what is commonly referred to as the opioid epidemic. The …

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States …

JR Morgan, BR Schackman, JA Leff, BP Linas… - Journal of substance …, 2018 - Elsevier
We investigated prescribing patterns for four opioid use disorder (OUD) medications: 1)
injectable naltrexone, 2) oral naltrexone, 3) sublingual or oralmucosal buprenorphine …

Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use

TNA Winkelman, VW Chang… - JAMA network open, 2018 - jamanetwork.com
Importance Health profiles and patterns of involvement in the criminal justice system among
people with various levels of opioid use are poorly defined. Data are needed to inform a …

Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial

L Tanum, KK Solli, JŠ Benth, A Opheim… - JAMA …, 2017 - jamanetwork.com
Importance To date, extended-release naltrexone hydrochloride has not previously been
compared directly with opioid medication treatment (OMT), currently the most commonly …